A randomized, parallel-group, single-center clinical study to examine the safety and effectiveness between argatroban and unfractionated heparin as anticoagulation in combination with clopidogrel and aspirin in coronary heart disease patients with moderate to high bleeding risk undergoing elective p
Active, not recruitingChiCTR-TRC-11001770
The Cardiovascular department, the General Hospital of PLA, No.28 Fuxing Road, Beijing, ChinaCoronary Artery Disease
Start: 2012-01-01Updated: 2017-04-18